Manager, Biopharma Applications, SCIEX
BIOGRAPHY
OCT 20, 2021 9:00 AM PDT
Comprehensive analysis of next generation biologics using advanced data interpretation software
Speaker
Event Date & Time
Date: October 20, 2021
Time: 9:00am (PDT), 12:00pm (EDT)
Abstract
Protein therapeutics is one of the major drug modalities in the biopharma industry. With more and more elucidation of disease pathology, the development of next generation protein therapeutics has become the trend of protein therapeutics development. Unfortunately, these next generation biologics (NGBs) such as fusion proteins exhibit additional levels of complexity beyond regular monoclonal antibody therapeutics. New methods, techniques and efficient data analysis software in liquid chromatography tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability. Here, a novel LC-MS/MS Q-TOF instrument (ZenoTOF 7600 system, SCIEX) equipped with a patented ion trap will be applied to the acquisition of intact mass and peptide map analysis of complex protein therapeutics. Furthermore, the advanced data processing capabilities of a novel software application (Biologics Explorer software, SCIEX) will be demonstrated.
Learning Objectives
- Discover how protein impurities in intact mass analyses can be easily identified with Biologics Explorer with its powerful visualization tool.
- Explore how to perform intact mass analysis for heavily glycosylated proteins.
- Demostrate how to get accurate site-specific N-linked glycan profiling.
- Explain how to accurately localize O-linked glycosylation.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...